EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 · Journal of Hepatology · 11K citations
https://doi.org/10.1016/j.jhep.2018.03.019
P
Peter Schirmacher
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
1.4K
Papers
62.2K
Citations
108
h-index
587
i10-index
Peter Schirmacher is an academic researcher from Heidelberg University. The author has contributed to research in topics: Cancer Genomics and Diagnostics & Liver Disease Diagnosis and Treatment & Lung Cancer Treatments and Mutations. The author has an h-index of 108, co-authored 1202 publications.
ORCID: 0000-0002-0950-3339Papers by this author
worksThe 2019 WHO classification of tumours of the digestive system
2019 · Histopathology · 3,859 citations
https://doi.org/10.1111/his.13975
Prognostic impact of tumour-infiltrating immune cells on biliary tract cancer
2013 · British Journal of Cancer · 267 citations
https://doi.org/10.1038/bjc.2013.610
Comprehensive Genomic and Transcriptomic Analysis for Guiding Therapeutic Decisions in Patients with Rare Cancers
2021 · Cancer Discovery · 264 citations
https://doi.org/10.1158/2159-8290.cd-21-0126
Framework and baseline examination of the German National Cohort (NAKO)
2022 · European Journal of Epidemiology · 155 citations
https://doi.org/10.1007/s10654-022-00890-5
Enhancer of zeste homolog 2 (EZH2) expression is an independent prognostic factor in renal cell carcinoma
2010 · BMC Cancer · 143 citations
https://doi.org/10.1186/1471-2407-10-524
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat